HSA — authorised 4 September 1958
- Marketing authorisation holder: OAK PHARMS AKORN
- Status: likely_approved
HSA authorised Diuril on 4 September 1958
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 4 September 1958.
OAK PHARMS AKORN holds the Singaporean marketing authorisation.